Cas 102152-13-6,2-<3-bromo-4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>-4-methylimidazole

102152-13-6

Post Buying Request

Basic information

Product Name: 2-<3-bromo-4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>-4-methylimidazole
Synonyms:
CAS NO:102152-13-6
Molecular Formula:
Molecular Weight: 490.397
EINECS: N/A
Product Categories: N/A
Mol File: 102152-13-6.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-<3-bromo-4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>-4-methylimidazole(CAS DataBase Reference)
NIST Chemistry Reference: 2-<3-bromo-4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>-4-methylimidazole(102152-13-6)
EPA Substance Registry System: 2-<3-bromo-4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>-4-methylimidazole(102152-13-6)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 102152-13-6(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

102152-13-6 Suppliers

Recommended suppliersmore

102152-13-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 102152-13-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,1,5 and 2 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 102152-13:
(8*1)+(7*0)+(6*2)+(5*1)+(4*5)+(3*2)+(2*1)+(1*3)=56
56 % 10 = 6
So 102152-13-6 is a valid CAS Registry Number.

102152-13-6Upstream product

102152-13-6Downstream Products

102152-13-6Relevant articles and documents

β1-Selective Adrenoceptor Antagonists: Examples of the 2-phenyl>imidazole Class. 2

Baldwin, John J.,Christy, Marcia E.,Denny, George H.,Habecker, Charles N.,Freedman, Mark B.,et al.

, p. 1065 - 1080 (2007/10/02)

An attempt to develop a highly cardioselective β-adrenoceptor antagonist devoid of intrinsic sympathomimetic activity (ISA) focused on exploring structure-activity relationships around (S)--amino>-2-hydroxypropoxy>phen

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 102152-13-6